U.S. Medical Equipment Stock News

NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

Insiders Favor Dave And 2 More High Growth Companies

Over the last 7 days, the United States market has risen by 4.9%, contributing to a notable 21% increase over the past year, with earnings expected to grow by 17% annually in the coming years. In this thriving environment, companies with high insider ownership often attract attention as they signal confidence from those closest to the business; Dave and two other high-growth companies exemplify this trend.
NYSE:VLN
NYSE:VLNSemiconductor

3 Promising Penny Stocks With Market Caps Under $500M

The market has climbed 4.9% in the last 7 days and is up 21% over the past year, with earnings forecasted to grow by 17% annually. Investing in penny stocks—once a buzzword but now more of a niche—can still open doors to growth opportunities, especially when these stocks are supported by strong financial health. For those looking to invest in smaller or newer companies, penny stocks can offer surprising value and potential for long-term growth.
NasdaqGS:MCBS
NasdaqGS:MCBSBanks

Top Dividend Stocks For Income In August 2026

Over the last 7 days, the United States market has risen by 4.9%, contributing to a robust 21% increase over the past year, with earnings forecasted to grow by 17% annually. In this environment, identifying dividend stocks that offer reliable income and potential for growth becomes essential for investors seeking to capitalize on these favorable market conditions.
NasdaqGS:RELY
NasdaqGS:RELYDiversified Financial

Revolut Stock Buzz Puts Remitly Toast And Payoneer In View

Revolut is back in the spotlight after its CEO Nik Storonsky linked a large share award to an ambitious $500b valuation target. The company is already valued at $115b in a secondary round, with talk of a $200b IPO and fresh licences in the UK and Australia, alongside a pending US application. That combination of richer incentives, global expansion and reported profit and revenue growth is now rippling across fintech. This article looks at how that news ties into three stocks from a broader...
NYSE:PG
NYSE:PGHousehold Products

Procter & Gamble (PG) Is Buying Thorne For $3.8 Billion To Push Into Wellness

Procter & Gamble (NYSE:PG) has entered a definitive agreement to acquire Thorne, a premium, science-backed health and wellness supplement brand. The planned transaction values Thorne at approximately US$3.8b and is aimed at expanding P&G's reach in self-care and preventative health. Procter & Gamble is best known for its large portfolio of household and personal care brands. This move, however, represents a further push into health and wellness. Thorne focuses on practitioner-trusted...
NasdaqGS:DOCU
NasdaqGS:DOCUSoftware

DocuSign (DOCU) Faces ARR Doubts, Is The Upside Already Priced In?

Investor focus on DocuSign (DOCU) has intensified after the latest quarter highlighted underwhelming annual recurring revenue growth and a negative customer acquisition cost payback period, raising questions about demand quality and sales efficiency. See our latest analysis for DocuSign. That cautious tone around DocuSign’s annual recurring revenue and sales efficiency sits against a sharp 25.7% 30 day share price return and a 23.7% 90 day share price return, yet the stock’s year to date...
NYSE:SPNT
NYSE:SPNTInsurance

SiriusPoint (SPNT) Earnings Beat Keeps Undervalued Narrative In Play

SiriusPoint (SPNT) stock is in focus after the company reported second quarter 2026 results, with net income and earnings per share above the prior year, along with an update on its long running share buyback program. See our latest analysis for SiriusPoint. The latest earnings beat and completed buyback tranche come after a mixed few weeks for SiriusPoint’s share price, with a 7 day share price return of down 9.05% and a 30 day share price return of down 2.84%. Even so, the year to date...